Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael Gerster is active.

Publication


Featured researches published by Michael Gerster.


Rapid Communications in Mass Spectrometry | 1998

Sequence verification of oligodeoxynucleotides and oligophosphorothioates using electrospray ionization (tandem) mass spectrometry

Ralf Lotz; Michael Gerster; Ernst Bayer

The collision induced dissociations of oligodeoxynucleotides, 5′ and 3′-terminal modified oligodeoxynucleotides and oligophosphorothioates, have been studied by using pneumatically assisted electrospray ionization mass spectrometry on a triple quadrupole instrument. Fragment ions were either produced in the collision gas cell of the triple quadrupole mass spectrometer or by nozzle-skimmer fragmentation. Sequence information was obtained for oligomers up to 21 bases and for 5′- and 3′-terminal modified 15-mers. Main fragments observed for oligodeoxynucleotides resulted from a-B- and w-type cleavages, and were most prominent when the lost base was guanine or cytosine. Positions containing thymine exhibited a low signal intensity for the corresponding a-B- and w-type fragment ions. Internal fragment ions containing from one up to four bases resulted from two subsequent a-b- and w-type cleavages, and were most prominent when both bases lost were guanine and/or cytosine. For oligophosphorothioates fragments resulting from a-B-, w-, b-, c-, x- and y-type cleavages were observed. In contrast to oligodeoxynucleotides none of the fragmentation reactions seems to be favoured, resulting in more sequence specific fragment ions. Compared to oligodeoxynucleotides, internal fragment ions were less prominent for oligophosphorothioates, possibly due to the many low energy fragmentation reactions possible for the intact oligomer and each fragment ion.


Langenbeck's Archives of Surgery | 1998

Growth inhibition of pancreatic tumor cells by modified antisense oligodeoxynucleotides

Alexander Fiedler; Christoph Knorre; Yvonne Franke; Doris Henne-Bruns; Bernd Kremer; Jutta Lüttges; Martin E. Maier; Michael Gerster; Konrad Bleicher; Ernst Bayer; Holger Kalthoff

Introduction: Pancreatic adenocarcinomas are largely resistant to apoptosis. More than 50% of pancreatic tumors reveal mutations in the p53 tumor suppressor gene. Methods: We investigated the growth of pancreatic tumor cells after downregulation of p53 protein expression by antisense oligodeoxynucleotides. Results: Proliferation and p53 expression of PancTu-I cells overexpressing mutant p53 protein were inhibited by antisense oligodeoxynucleotide treatment. When analyzed, two of three other pancreatic tumor cell lines with mutated p53 were also inhibited in their growth. Two of two wild-type (wt) p53 pancreatic tumor cells were not significantly influenced by p53 expression and were, only to a lesser extent, affected in their proliferation. K562 cells (lacking p53 mRNA) and normal human skin fibroblasts used as a target mismatch control showed no changes in proliferation rates with treatment. The different biological effects in the various cells were not caused by differences in the uptake of the oligodeoxynucleotides as monitored by confocal laser-scanning microscopy. Conclusions: Truncation and 5′- and 3′-lipophilic modifications of the oligodeoxynucleotides drastically enhanced the growth inhibition of PancTu-I cells, which were resistant to apoptosis-inducing agents. Furthermore, a higher sequence-specificity of the observed effects was achieved with these compounds.


Zeitschrift für Naturforschung. B, A journal of chemical sciences | 1997

OPTIMIZED LARGE SCALE SYNTHESIS OF PHOSPHOROTHIOATE OLIGONUCLEOTIDES ON PS-PEG SUPPORTS

Michael Gerster; Martin E. Maier; Nils Clausen; Jens Schewitz; Ernst Bayer

Sulphurization is a crucial step during synthesis of phosphorothioate oligonucleotides. Insufficient reaction leads to inhomogeneous products with phosphodiester defects and subsequently to destabilization of the oligomers in biological media. To achieve a maximum extent of sulphur incorporation, various sulphurizing agents have been investigated. Solely, the use of Beaucage reagent provided satisfactory results on PS-PEG supports. Based on our investigations in small scale synthesis (1 μmol) with continuous-flow technique, upscaling to the 0.1-0.25 mmolar range has been achieved using a peptide synthesizer. The syntheses were performed in batch mode with standard phosphoramidite chemistry. Additionally, large scale synthesis of a phosphodiester oligonucleotide has been carried out on PS-PEG with optimized protocols and compared to small scale synthesis on different supports. Products were analysed by 31P NMR, capillary gel electrophoresis and electrospray mass spectrometry. An extent of sulphurization of 99% and coupling effiencies of more than 99% were obtained and the products proved to have similar purity compared to small scale syntheses on CPG


Analytical Chemistry | 1999

Interaction of chemically modified antisense oligonucleotides with sense DNA : A label-free interaction study with reflectometric interference spectroscopy

Matthias Sauer; Andreas Brecht; Klaus Charisse; Martin E. Maier; Michael Gerster; Ivo Stemmler; Günter Gauglitz; Ernst Bayer


Analytical Chemistry | 1998

Quantitation of Phosphorothioate Oligonucleotides in Human Blood Plasma Using a Nanoparticle-Based Method for Solid-Phase Extraction

Martin E. Maier; Hans Fritz; Michael Gerster; Jens Schewitz; Ernst Bayer


Archive | 1998

Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles

Ernst Bayer; Hans Fritz; Martin Maier; Jens Schewitz; Michael Gerster


Analytical Biochemistry | 1998

Quantitative analysis of modified antisense oligonucleotides in biological fluids using cationic nanoparticles for solid-phase extraction.

Michael Gerster; Jens Schewitz; Hans Fritz; Martin E. Maier; Ernst Bayer


Archive | 2001

Oligonukleotide, diese enthaltende mittel und deren verwendung

Ernst Bayer; Thomas Ketterer; Holger Kalthoff; Hendrik Ungefroren; Michael Gerster; Alexander Fiedler


Archive | 2000

Anwendung chemisch modifizierter Oligodesoxyribonukleotide zur Unterdrückung der Proliferation von humanem Pankreastumor Use of chemically modified oligodeoxyribonucleotides of suppressing the proliferation of human pancreatic tumor

Ernst Bayer; Thomas Ketterer; Holger Kalthoff; Hendrik Ungefroren; Michael Gerster; Alexander Fiedler


Archive | 2000

Application of chemically modified oligodeoxyribonucleotides to suppress the proliferation of human pancreatic tumor

Ernst Bayer; Thomas Ketterer; Holger Kalthoff; Hendrik Ungefroren; Michael Gerster; Alexander Fiedler

Collaboration


Dive into the Michael Gerster's collaboration.

Top Co-Authors

Avatar

Ernst Bayer

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hans Fritz

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin Maier

Alnylam Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge